MétaCan
Menu
Back to cohort
Record W2553667979 · doi:10.1182/blood.v104.11.394.394

Microgranular Variant (M3V) of Acute Promyelocytic Leukemia (APL) Does Not Have a Worse Prognosis than Classical APL in the Atra Era: A Report of 153 Patients Treated on Intergroup 0129 and Pethema LPA96 and LPA99.

2004· article· en· W2553667979 on OpenAlexaff
Martin S. Tallman, Haesook T. Kim, Charles A. Schiffer, Frederick R. Appelbaum, James H. Feusner, Angela Ogden, L. E. Shepherd, Cheryl L. Willman, Clara D. Bloomfield, Jacob M. Rowe, Richard A. Larson, Peter H. Wiernik, Guillermo Martı́n, Chelo Rayón, Javier de la Serna, Concha Rivas, José D. González‐San Miguel, Guillermo Debén, Miguel Á. Sanz

Bibliographic record

VenueBlood · 2004
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicRetinoids in leukemia and cellular processes
Canadian institutionsOntario Institute for Cancer Research
Fundersnot available
KeywordsMedicineIdarubicinAcute promyelocytic leukemiaCytarabineInternal medicineDaunorubicinChemotherapyGastroenterologyChemotherapy regimenWhite blood cellInduction chemotherapyAnthracyclineOncologySurgeryCancerBiologyRetinoic acid

Abstract

fetched live from OpenAlex

Abstract The microgranular variant (M3V) accounts for 15–20% of patients (pts) with acute promyelocytic leukemia (APL). Historically, it has been associated with a higher white blood cell count (WBC) at diagnosis and an inferior outcome compared to classical morphology. Pts with APL treated with ATRA plus chemotherapy strategies have a 3–5 year DFS of 70–80%. The prognosis of pts with M3V treated with ATRA-containing chemotherapy strategies has not been adequately studied. This analysis included 153 patients with M3V entered on the North American Intergroup protocol 0129 (INT0129), a randomized phase III study of either ATRA (INT, ATRA)or daunorubicin/cytarabine for induction (INT, DA) and ATRA maintenance or observation after intensive consolidation or PETHEMA protocols LPA96 and LPA99 in which all pts received ATRA plus idarubicin for induction, intensive consolidation and ATRA plus low-dose chemotherapy for maintenance (PETHEMA, ATRA). The median age was 39 years (range 3–79), the median WBC was 14.5 K/μL (range 0.4–550), and the median platelet count was 25 K/μL (range 1.8 – 207.0). The median follow-up time for pts on INT0129 is 9.7 years, and for pts on PETHEMA LPA96 and LPA99 is 3.2 years. The 3-year disease-free (DFS) and overall survival (OS) analyses are shown in the table below. N Median (in mo) (95% CI) DFS p-value N Median (in mo) (95% CI) OS p-value *comparison between ATRA (INT+PETHEMA) and DA; **comparison among WBC groups. NE: not estimable or not reached in this analysis INT+PETHEMA, ATRA 106 NE 77% <0.0001* 128 NE 75% <0.0001* INT, ATRA 19 NE 63% 24 NE 71% PETHEMA, ATRA 87 NE 81% 104 NE 76% INT, DA 20 8.3(6.7, 12.6) 15% 25 19.4(10.4, 41.8) 32% INT+PETHEMA, ATRA 0<WBC<10K 47 NE 89% 0.01** 52 NE 90% 0.07** 10K≤WBC<50K 37 NE 78% 48 NE 69% WBC≥50K 22 NE 54% 28 NE 58% INT, DA 0<WBC<10K 8 8.4(3.0, 24.6) 13% 0.94** 10 19.5(8.6, 41.8) 30% 0.32** 10K≤WBC<50K 6 9.2(5.2, 12.6) 17% 8 56.6(10.3, NE) 50% WBC≥50K 6 7.9(7.4, 15.9) 17% 7 13.6(6.8, 22.2) 14% In a Cox regression model, when age, gender, WBC, platelet, Hgb, ATRA treatment (ATRA vs DA), and source of pts (INT vs. PETHEMA) are included, only ATRA induction treatment (HR=0.16, p-value=0.0005) appears to be a significant prognostic factor for DFS, and age, WBC, and ATRA induction treatment (HR=0.38, p-value=0.03) for OS. These data suggest that the outcome for pts with APL M3V is excellent, influenced by the WBC at diagnosis and is not different than that of pts with classical morphology when treated with ATRA-containing strategies.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.182
Threshold uncertainty score0.613

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.217
Teacher spread0.212 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations5
Published2004
Admission routes1
Has abstractyes

Explore more

Same venueBloodSame topicRetinoids in leukemia and cellular processesFrench-language works237,207